101 related articles for article (PubMed ID: 29479035)
1. A pharmacologic increase in activity of plasma transaminase derived from small intestine in animals receiving an acyl CoA: diacylglycerol transferase (DGAT) 1 inhibitor.
Yokoyama H; Kobayashi A; Kondo K; Oshida SI; Takahashi T; Masuyama T; Shoda T; Sugai S
J Toxicol Sci; 2018; 43(2):135-157. PubMed ID: 29479035
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterization of [trans-5'-(4-amino-7,7-dimethyl-2-trifluoromethyl-7H-pyrimido[4,5-b][1,4]oxazin-6-yl)-2',3'-dihydrospiro(cyclohexane-1,1'-inden)-4-yl]acetic acid monobenzenesulfonate (JTT-553), a novel acyl CoA:diacylglycerol transferase (DGAT) 1 inhibitor.
Tomimoto D; Okuma C; Ishii Y; Akiyama Y; Ohta T; Kakutani M; Ohkuma Y; Ogawa N
Biol Pharm Bull; 2015; 38(2):263-9. PubMed ID: 25747985
[TBL] [Abstract][Full Text] [Related]
3. JTT-553, a novel Acyl CoA:diacylglycerol acyltransferase (DGAT) 1 inhibitor, improves glucose metabolism in diet-induced obesity and genetic T2DM mice.
Tomimoto D; Okuma C; Ishii Y; Kobayashi A; Ohta T; Kakutani M; Imanaka T; Ogawa N
J Pharmacol Sci; 2015 Sep; 129(1):51-8. PubMed ID: 26354408
[TBL] [Abstract][Full Text] [Related]
4. Acyl-CoA:diacylglycerol acyltransferase 1 inhibition in the small intestine increases plasma transaminase activity via the activation of protein kinase C pathway.
Yokoyama H; Masuyama T; Tanaka Y; Tsubakihara I; Kondo K; Yoshinari K
J Toxicol Sci; 2022; 47(1):19-30. PubMed ID: 34987138
[TBL] [Abstract][Full Text] [Related]
5. Diacylglycerol acyltransferase-1 inhibition enhances intestinal fatty acid oxidation and reduces energy intake in rats.
Schober G; Arnold M; Birtles S; Buckett LK; Pacheco-López G; Turnbull AV; Langhans W; Mansouri A
J Lipid Res; 2013 May; 54(5):1369-84. PubMed ID: 23449193
[TBL] [Abstract][Full Text] [Related]
6. Characterization of acyl-coenzyme A:diacylglycerol acyltransferase (DGAT) enzyme of human small intestine.
Hiramine Y; Tanabe T
J Physiol Biochem; 2011 Jun; 67(2):259-64. PubMed ID: 21369919
[TBL] [Abstract][Full Text] [Related]
7. Discovery of 6-phenylpyrimido[4,5-b][1,4]oxazines as potent and selective acyl CoA:diacylglycerol acyltransferase 1 (DGAT1) inhibitors with in vivo efficacy in rodents.
Fox BM; Sugimoto K; Iio K; Yoshida A; Zhang JK; Li K; Hao X; Labelle M; Smith ML; Rubenstein SM; Ye G; McMinn D; Jackson S; Choi R; Shan B; Ma J; Miao S; Matsui T; Ogawa N; Suzuki M; Kobayashi A; Ozeki H; Okuma C; Ishii Y; Tomimoto D; Furakawa N; Tanaka M; Matsushita M; Takahashi M; Inaba T; Sagawa S; Kayser F
J Med Chem; 2014 Apr; 57(8):3464-83. PubMed ID: 24670009
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological inhibition to examine the role of DGAT1 in dietary lipid absorption in rodents and humans.
Maciejewski BS; LaPerle JL; Chen D; Ghosh A; Zavadoski WJ; McDonald TS; Manion TB; Mather D; Patterson TA; Hanna M; Watkins S; Gibbs EM; Calle RA; Steppan CM
Am J Physiol Gastrointest Liver Physiol; 2013 Jun; 304(11):G958-69. PubMed ID: 23558010
[TBL] [Abstract][Full Text] [Related]
9. Intestinal acyl-CoA:diacylglycerol acyltransferase 2 overexpression enhances postprandial triglyceridemic response and exacerbates high fat diet-induced hepatic triacylglycerol storage.
Uchida A; Slipchenko MN; Eustaquio T; Leary JF; Cheng JX; Buhman KK
Biochim Biophys Acta; 2013 Aug; 1831(8):1377-85. PubMed ID: 23643496
[TBL] [Abstract][Full Text] [Related]
10. Intestinal DGAT1 deficiency reduces postprandial triglyceride and retinyl ester excursions by inhibiting chylomicron secretion and delaying gastric emptying.
Ables GP; Yang KJ; Vogel S; Hernandez-Ono A; Yu S; Yuen JJ; Birtles S; Buckett LK; Turnbull AV; Goldberg IJ; Blaner WS; Huang LS; Ginsberg HN
J Lipid Res; 2012 Nov; 53(11):2364-79. PubMed ID: 22911105
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of diethyl-2-({3-dimethylcarbamoyl-4-[(4'-trifluoromethylbiphenyl-2-carbonyl)amino]phenyl}acetyloxymethyl)-2-phenylmalonate (JTT-130), an intestine-specific inhibitor of microsomal triglyceride transfer protein.
Mera Y; Odani N; Kawai T; Hata T; Suzuki M; Hagiwara A; Katsushima T; Kakutani M
J Pharmacol Exp Ther; 2011 Feb; 336(2):321-7. PubMed ID: 20974698
[TBL] [Abstract][Full Text] [Related]
12. Targeting Acyl-CoA:diacylglycerol acyltransferase 1 (DGAT1) with small molecule inhibitors for the treatment of metabolic diseases.
Cao J; Zhou Y; Peng H; Huang X; Stahler S; Suri V; Qadri A; Gareski T; Jones J; Hahm S; Perreault M; McKew J; Shi M; Xu X; Tobin JF; Gimeno RE
J Biol Chem; 2011 Dec; 286(48):41838-41851. PubMed ID: 21990351
[TBL] [Abstract][Full Text] [Related]
13. Diacylglycerol acyltransferase 1/2 inhibition induces dysregulation of fatty acid metabolism and leads to intestinal barrier failure and diarrhea in mice.
Takemoto K; Fukasaka Y; Yoshimoto R; Nambu H; Yukioka H
Physiol Rep; 2020 Aug; 8(15):e14542. PubMed ID: 32786057
[TBL] [Abstract][Full Text] [Related]
14. Hepatic synthesis of triacylglycerols containing medium-chain fatty acids is dominated by diacylglycerol acyltransferase 1 and efficiently inhibited by etomoxir.
Wunderling K; Leopold C; Jamitzky I; Yaghmour M; Zink F; Kratky D; Thiele C
Mol Metab; 2021 Mar; 45():101150. PubMed ID: 33359403
[TBL] [Abstract][Full Text] [Related]
15. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, suppresses high fat diet-induced obesity and glucose intolerance in Sprague-Dawley rats.
Hata T; Mera Y; Tadaki H; Kuroki Y; Kawai T; Ohta T; Kakutani M
Diabetes Obes Metab; 2011 May; 13(5):446-54. PubMed ID: 21255216
[TBL] [Abstract][Full Text] [Related]
16. Intestine-specific expression of acyl CoA:diacylglycerol acyltransferase 1 reverses resistance to diet-induced hepatic steatosis and obesity in Dgat1-/- mice.
Lee B; Fast AM; Zhu J; Cheng JX; Buhman KK
J Lipid Res; 2010 Jul; 51(7):1770-80. PubMed ID: 20147738
[TBL] [Abstract][Full Text] [Related]
17. Mangiferin treatment inhibits hepatic expression of acyl-coenzyme A:diacylglycerol acyltransferase-2 in fructose-fed spontaneously hypertensive rats: a link to amelioration of fatty liver.
Xing X; Li D; Chen D; Zhou L; Chonan R; Yamahara J; Wang J; Li Y
Toxicol Appl Pharmacol; 2014 Oct; 280(2):207-15. PubMed ID: 25123789
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological inhibition of diacylglycerol acyltransferase 1 reduces body weight and modulates gut peptide release--potential insight into mechanism of action.
Liu J; Gorski JN; Gold SJ; Chen D; Chen S; Forrest G; Itoh Y; Marsh DJ; McLaren DG; Shen Z; Sonatore L; Carballo-Jane E; Craw S; Guan X; Karanam B; Sakaki J; Szeto D; Tong X; Xiao J; Yoshimoto R; Yu H; Roddy TP; Balkovec J; Pinto S
Obesity (Silver Spring); 2013 Jul; 21(7):1406-15. PubMed ID: 23671037
[TBL] [Abstract][Full Text] [Related]
19. DGAT1 is not essential for intestinal triacylglycerol absorption or chylomicron synthesis.
Buhman KK; Smith SJ; Stone SJ; Repa JJ; Wong JS; Knapp FF; Burri BJ; Hamilton RL; Abumrad NA; Farese RV
J Biol Chem; 2002 Jul; 277(28):25474-9. PubMed ID: 11959864
[TBL] [Abstract][Full Text] [Related]
20. Enzyme activities of intestinal triacylglycerol and phosphatidylcholine biosynthesis in Atlantic salmon (Salmo salar L.).
Oxley A; Torstensen BE; Rustan AC; Olsen RE
Comp Biochem Physiol B Biochem Mol Biol; 2005 May; 141(1):77-87. PubMed ID: 15820137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
